UCL HUNTINGTON’S DISEASE RESEARCH

INFORMATION FOR SCIENTISTS, CLINICIANS, PATIENTS, RELATIVES AND CARERS

HDClarity

HDClarity

Studying CSF to identify and validate biomarkers for HD clinical development.

HDClarity aims to collect a large amount of high quality cerebrospinal fluid (CSF) and blood samples from participants who carry the HD gene and matched controls. The samples will be used to further research into identifying biomarkers which will help in the development of new treatments for HD.

UCL HD Centre is coordinating HDClarity but not recruiting participants directly. Participants will attend other sites to complete the two study visits; screening visit then a sampling visit. The CSF is collected via a lumbar puncture during the sampling visit.

If you would like more information, please visit http://hdclarity.net/

Updated June 7, 2017